- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0013077

About QMS Medical Allied Services Limited
Data last updated:
QMS Medical Allied Services Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the wholesale trading and distribution segment of the trading and commerce sector. It was incorporated on 14 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN L33309MH2017PLC299748. Its GSTIN is 27AAACQ4954G1ZB (Maharashtra). The company holds 4 GST registrations, of which 3 are active. It is a listed company as per MCA records. Its shares are listed on NSE: QMSMEDI.
The company has an authorised share capital of ₹23 Cr and a paid-up capital of ₹19.34 Cr. It was formerly known as Qms Medical Allied Services Private Limited. It is led by directors including Mahesh Pahalraj Makhija (Managing Director) and Prajwal Jayasheela Poojari.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹172.88 Cr, a growth of 10.8% compared to the previous year. For the same year it recorded a net profit of ₹10.07 Cr (net margin 5.8%) and EBITDA of ₹26.62 Cr (EBITDA margin 15.4%). The net worth stands at ₹104.2 Cr (up 16.2% YoY). Total assets are valued at ₹189.1 Cr (up 12.8% YoY).
The company has about 83 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Qms Medical Allied Services and Qms Mas. As per MCA filings, the company has open charges of ₹86.2 Cr and satisfied charges of ₹117.66 Cr on record. The company has 4 deals on record (2 secondary share transfers, 1 funding round, 1 ipo), with disclosed funding of ₹3.75 Cr; the latest was in October 2022.
QMS Medical Allied Services Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0013077). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website qmsmas.com.
Company details
CIN history
QMS Medical Allied Services has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L33309MH2017PLC299748, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L33309MH2017PLC299748 | Current |
| U33309MH2017PLC299748 | Previous |
| U33309MH2017PTC299748 | Previous |
Recognitions & Rankings of QMS Medical Allied Services
Contact details
QMS Medical Allied Services Limited's registered office is in Mumbai, Maharashtra.
- Social Media
- Registered AddressA1 A2/B1 B2 Navkala Bharti Bldg Plot No16 Prabhat Colony Opp Near Santacruz Bus Depot Sant, Acruz East, Mumbai, Maharashtra, India – 400055
- IndustryTrading, Wholesale, Other Wholesale
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
QMS Medical Allied Services operates two associated brands: QMS MEDICAL ALLIED SERVICES and QMS MAS. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Online store for medical devices, instruments, and supplies in India. | qmsmeds.com | |
| Provider of digital marketing & scientific solution services for medical devices manufacturers | qmsmas.com |
Business activity
The main business activities of QMS Medical Allied Services are trade and hospital and medical care. In detail, this covers wholesale trading and other hospital and medical care activities. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of QMS Medical Allied Services Limited, buy the company report.
Financials of QMS Medical Allied Services Limited
FY 2025-26 filings availableQMS Medical Allied Services Limited reported revenue of ₹172.88 Cr (up 10.8% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Income statement | |||
| Revenue | 173 | 156 | 122 |
| Revenue growth | +10.8% | +27.7% | - |
| EBITDA | 26.62 | 25.40 | 18.34 |
| EBITDA margin | +15.4% | +16.3% | +15.0% |
| Profit before tax | 16.38 | 18.65 | 12.23 |
| Net profit | 10.07 | 12.07 | 9.00 |
| Net profit margin | +5.8% | +7.7% | +7.4% |
| EPS (₹) | 6.32 | 6.77 | 5.04 |
| Balance sheet | |||
| Total assets | 189 | 168 | 113 |
| Net worth | 104 | 89.71 | 78.51 |
| Total debt | 74.48 | 60.28 | 34.54 |
| Cash & bank | 1.20 | 1.07 | 0.31 |
| Net working capital | 113 | 94.52 | 81.88 |
| Cash flow | |||
| Cash from operations | 19.44 | 19.17 | 1.36 |
| Cash from investing | (20.42) | (45.49) | (2.73) |
| Cash from financing | 1.11 | 26.84 | 0.41 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 52.52 | 56.87 | 44.42 | 37.26 | 44.70 | 46.50 | 44.58 | 43.87 |
| Revenue growth (YoY) | +17.5% | +22.3% | -0.4% | -15.1% | +20.2% | +53.1% | - | - |
| Other income | 0.22 | 0.42 | 0.22 | 0.30 | 0.22 | 0.32 | 1.09 | 0.19 |
| EBITDA | 6.52 | 8.31 | 5.91 | 6.75 | 6.92 | 6.54 | 6.37 | 6.95 |
| EBITDA margin | +12.4% | +14.6% | +13.3% | +18.1% | +15.5% | +14.1% | +14.3% | +15.8% |
| Depreciation | 1.60 | 1.47 | 1.39 | 1.02 | 0.94 | 0.93 | 1.36 | 0.86 |
| Interest | 1.86 | 1.71 | 2.08 | 1.75 | 1.36 | 1.44 | 1.41 | 1.31 |
| Profit before tax | 3.28 | 5.55 | 2.66 | 4.28 | 4.84 | 4.49 | 4.69 | 4.97 |
| Tax | 0.84 | 1.59 | 0.78 | 1.10 | 1.27 | 1.33 | 1.09 | 1.50 |
| Net profit | 2.44 | 3.96 | 1.88 | 3.18 | 3.57 | 3.16 | 3.60 | 3.47 |
| EPS (₹) | 1.26 | 2.05 | 0.97 | 1.24 | 1.71 | 2.20 | 1.87 | 1.63 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 152 | 145 | 122 | 104 | 146 | 122 | 72.74 |
| Revenue growth | +5.1% | +18.6% | +17.4% | -28.9% | +19.9% | +67.8% | - |
| EBITDA | 21.08 | 23.33 | 18.34 | 11.33 | 16.64 | 16.99 | 9.60 |
| EBITDA margin | +13.8% | +16.1% | +15.0% | +10.9% | +11.4% | +13.9% | +13.2% |
| Profit before tax | 9.31 | 14.43 | 12.23 | 8.71 | 14.46 | 14.90 | 8.72 |
| Net profit | 6.59 | 10.42 | 9.00 | 6.38 | 9.69 | 10.91 | 6.32 |
| Net profit margin | +4.3% | +7.2% | +7.4% | +6.1% | +6.6% | +8.9% | +8.7% |
| EPS (₹) | 3.51 | 5.84 | 5.04 | 3.57 | 28.40 | 29.02 | 21.00 |
| Balance sheet | |||||||
| Total assets | 196 | 166 | 113 | 96.01 | 63.01 | 39.93 | 21.01 |
| Net worth | 104 | 88.04 | 78.51 | 70.40 | 31.03 | 20.32 | 9.41 |
| Total debt | 90.92 | 77.25 | 2.37 | 25.52 | 31.97 | 19.60 | 11.60 |
| Cash & bank | 0.11 | 0.39 | 0.31 | 2.37 | 2.16 | 1.38 | 0.66 |
| Net working capital | 103 | 88.08 | 81.88 | 65.60 | 54.85 | 29.40 | 17.58 |
| Cash flow | |||||||
| Cash from operations | 18.77 | 26.09 | 1.36 | (7.54) | (1.72) | 1.88 | 4.18 |
| Cash from investing | (18.27) | (48.90) | (1.78) | (25.10) | 2.37 | (7.84) | (3.66) |
| Cash from financing | (0.78) | 22.88 | (1.07) | 31.74 | 0.13 | 6.69 | 0.00 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 50.94 | 52.34 | 39.19 | 29.54 | 41.25 | 42.32 | 42.38 | 39.38 |
| Revenue growth (YoY) | +23.5% | +23.7% | -7.5% | -25.0% | +26.0% | +39.4% | - | - |
| Other income | 0.08 | 0.25 | 0.07 | 0.13 | 0.00 | 0.15 | 0.13 | 0.12 |
| Total expenses | 44.65 | 45.34 | 34.81 | 25.77 | 35.12 | 35.99 | 34.56 | 34.05 |
| EBITDA | 6.29 | 7.00 | 4.38 | 3.77 | 6.13 | 6.33 | 7.82 | 5.33 |
| EBITDA margin | +12.3% | +13.4% | +11.2% | +12.8% | +14.9% | +15.0% | +18.5% | +13.5% |
| Depreciation | 1.43 | 1.31 | 1.22 | 0.92 | 0.83 | 0.83 | 0.90 | 0.91 |
| Interest | 2.21 | 2.05 | 2.38 | 2.06 | 1.73 | 1.77 | 2.73 | 1.31 |
| Profit before tax | 2.73 | 3.89 | 0.85 | 0.92 | 3.57 | 3.88 | 4.32 | 3.23 |
| Tax | 0.69 | 1.22 | 0.24 | 0.34 | 0.93 | 1.20 | 1.26 | 0.89 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 52.52 | 56.87 | 44.42 | 37.26 | 44.70 | 46.50 | 44.58 | 43.87 |
| Revenue growth (YoY) | +17.5% | +22.3% | -0.4% | -15.1% | +20.2% | +53.1% | - | - |
| Other income | 0.22 | 0.42 | 0.22 | 0.30 | 0.22 | 0.32 | 1.09 | 0.19 |
| EBITDA | 6.52 | 8.31 | 5.91 | 6.75 | 6.92 | 6.54 | 6.37 | 6.95 |
| EBITDA margin | +12.4% | +14.6% | +13.3% | +18.1% | +15.5% | +14.1% | +14.3% | +15.8% |
| Depreciation | 1.60 | 1.47 | 1.39 | 1.02 | 0.94 | 0.93 | 1.36 | 0.86 |
| Interest | 1.86 | 1.71 | 2.08 | 1.75 | 1.36 | 1.44 | 1.41 | 1.31 |
| Profit before tax | 3.28 | 5.55 | 2.66 | 4.28 | 4.84 | 4.49 | 4.69 | 4.97 |
| Tax | 0.84 | 1.59 | 0.78 | 1.10 | 1.27 | 1.33 | 1.09 | 1.50 |
| Net profit | 2.44 | 3.96 | 1.88 | 3.18 | 3.57 | 3.16 | 3.60 | 3.47 |
| EPS (₹) | 1.26 | 2.05 | 0.97 | 1.24 | 1.71 | 2.20 | 1.87 | 1.63 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Revenue | 173 | 156 | 122 |
| Revenue growth | +10.8% | +27.7% | - |
| Other income | 1.06 | 1.72 | 0.46 |
| Total expenses | 146 | 131 | 104 |
| Employee cost | 0.00 | 7.54 | 3.67 |
| EBITDA | 26.62 | 25.40 | 18.34 |
| EBITDA margin | +15.4% | +16.3% | +15.0% |
| Depreciation | 4.61 | 3.83 | 3.44 |
| Interest | 6.69 | 4.64 | 3.13 |
| Profit before tax | 16.38 | 18.65 | 12.23 |
| Tax | 4.51 | 4.96 | 3.23 |
| Net profit | 10.07 | 12.07 | 9.00 |
| Net profit margin | +5.8% | +7.7% | +7.4% |
| EPS (₹) | 6.32 | 6.77 | 5.04 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Equity & liabilities | |||
| Share capital | 19.34 | 17.85 | 17.85 |
| Reserves & surplus | 84.86 | 71.86 | 60.66 |
| Shareholders' funds (net worth) | 104 | 89.71 | 78.51 |
| Minority interest | 9.77 | 17.39 | 0.00 |
| Secured loans | 69.01 | 54.82 | 33.46 |
| Unsecured loans | 5.47 | 5.46 | 1.08 |
| Total debt | 74.48 | 60.28 | 34.54 |
| Total liabilities | 189 | 168 | 113 |
| Assets | |||
| Gross block | 72.25 | 66.21 | 30.03 |
| Net block | 54.62 | 52.42 | 23.58 |
| Capital work in progress | 2.83 | 3.19 | 2.06 |
| Investments | 5.46 | 3.23 | 2.11 |
| Inventories | 45.92 | 39.33 | 37.58 |
| Sundry debtors | 67.32 | 57.93 | 41.39 |
| Cash & bank balances | 1.20 | 1.07 | 0.31 |
| Loans & advances | 22.12 | 18.48 | 24.39 |
| Total current assets | 137 | 117 | 104 |
| Total current liabilities | 23.75 | 22.29 | 21.79 |
| Net working capital | 113 | 94.52 | 81.88 |
| Total assets | 189 | 168 | 113 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Opening cash | 1.06 | 0.31 | 1.27 |
| Net cash from operating activities | 19.44 | 19.17 | 1.36 |
| Net cash from investing activities | (20.42) | (45.49) | (2.73) |
| Net cash from financing activities | 1.11 | 26.84 | 0.41 |
| Net change in cash | 0.13 | 0.52 | (0.96) |
| Closing cash | 1.20 | 1.07 | 0.31 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Growth | |||
| Sales growth | +10.8% | +27.7% | - |
| EBITDA growth | +4.8% | +38.5% | - |
| PBT growth | -11.9% | +52.6% | +9997.0% |
| Net income growth | -16.6% | +34.1% | - |
| Profitability & leverage | |||
| Net income margin | +6.9% | +8.8% | +7.4% |
| Return on capital employed | +14.0% | +17.7% | +13.6% |
| Return on net worth | +12.3% | +16.3% | +11.5% |
| Debt / equity | 0.69 | 0.56 | 0.44 |
| Long-term debt / equity | 0.08 | 0.07 | 0.03 |
| Interest cover | 29.85 | 21.50 | 21.01 |
| Efficiency & per share | |||
| Fixed asset turnover | 2.50 | 3.24 | 4.07 |
| Inventory turnover | 4.06 | 4.06 | 3.25 |
| Debtors turnover | 2.76 | 3.14 | 2.95 |
| EPS (₹) | 5.24 | 6.77 | 5.04 |
| Dividend per share (₹) | 0.50 | 0.50 | 0.00 |
| Book value per share (₹) | 53.88 | 50.26 | 43.99 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 50.94 | 52.34 | 39.19 | 29.54 | 41.25 | 42.32 | 42.38 | 39.38 |
| Revenue growth (YoY) | +23.5% | +23.7% | -7.5% | -25.0% | +26.0% | +39.4% | - | - |
| Other income | 0.08 | 0.25 | 0.07 | 0.13 | 0.00 | 0.15 | 0.13 | 0.12 |
| Total expenses | 44.65 | 45.34 | 34.81 | 25.77 | 35.12 | 35.99 | 34.56 | 34.05 |
| EBITDA | 6.29 | 7.00 | 4.38 | 3.77 | 6.13 | 6.33 | 7.82 | 5.33 |
| EBITDA margin | +12.3% | +13.4% | +11.2% | +12.8% | +14.9% | +15.0% | +18.5% | +13.5% |
| Depreciation | 1.43 | 1.31 | 1.22 | 0.92 | 0.83 | 0.83 | 0.90 | 0.91 |
| Interest | 2.21 | 2.05 | 2.38 | 2.06 | 1.73 | 1.77 | 2.73 | 1.31 |
| Profit before tax | 2.73 | 3.89 | 0.85 | 0.92 | 3.57 | 3.88 | 4.32 | 3.23 |
| Tax | 0.69 | 1.22 | 0.24 | 0.34 | 0.93 | 1.20 | 1.26 | 0.89 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 152 | 145 | 122 | 104 | 146 | 122 | 72.74 |
| Revenue growth | +5.1% | +18.6% | +17.4% | -28.9% | +19.9% | +67.8% | - |
| Other income | 0.36 | 0.46 | 0.46 | 0.74 | 1.42 | 0.06 | 0.04 |
| Total expenses | 131 | 122 | 104 | 92.71 | 130 | 105 | 63.14 |
| Employee cost | 0.00 | 6.00 | 3.67 | 2.61 | 3.83 | 1.56 | 0.92 |
| EBITDA | 21.08 | 23.33 | 18.34 | 11.33 | 16.64 | 16.99 | 9.60 |
| EBITDA margin | +13.8% | +16.1% | +15.0% | +10.9% | +11.4% | +13.9% | +13.2% |
| Depreciation | 4.12 | 3.40 | 3.44 | 1.07 | 1.16 | 0.74 | 0.36 |
| Interest | 8.01 | 5.96 | 3.13 | 2.29 | 2.44 | 1.41 | 0.56 |
| Profit before tax | 9.31 | 14.43 | 12.23 | 8.71 | 14.46 | 14.90 | 8.72 |
| Tax | 2.72 | 4.00 | 3.23 | 2.33 | 3.77 | 3.99 | 2.40 |
| Net profit | 6.59 | 10.42 | 9.00 | 6.38 | 9.69 | 10.91 | 6.32 |
| Net profit margin | +4.3% | +7.2% | +7.4% | +6.1% | +6.6% | +8.9% | +8.7% |
| EPS (₹) | 3.51 | 5.84 | 5.04 | 3.57 | 28.40 | 29.02 | 21.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 19.34 | 17.85 | 17.85 | 17.85 | 3.76 | 3.76 | 3.01 |
| Reserves & surplus | 84.88 | 70.19 | 60.66 | 52.55 | 27.27 | 16.56 | 6.40 |
| Shareholders' funds (net worth) | 104 | 88.04 | 78.51 | 70.40 | 31.03 | 20.32 | 9.41 |
| Secured loans | 85.45 | 71.79 | 0.00 | 25.52 | 31.38 | 18.05 | 8.99 |
| Unsecured loans | 5.47 | 5.46 | 2.37 | 0.00 | 0.59 | 1.55 | 2.61 |
| Total debt | 90.92 | 77.25 | 2.37 | 25.52 | 31.97 | 19.60 | 11.60 |
| Total liabilities | 196 | 166 | 113 | 96.01 | 63.01 | 39.93 | 21.01 |
| Assets | |||||||
| Gross block | 37.90 | 32.07 | 30.03 | 28.37 | 9.91 | 11.30 | 3.63 |
| Net block | 24.65 | 22.33 | 23.58 | 25.36 | 7.97 | 10.17 | 3.24 |
| Capital work in progress | 2.64 | 2.93 | 2.06 | 1.15 | 0.00 | 0.00 | 0.00 |
| Investments | 63.09 | 48.33 | 2.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 45.92 | 39.28 | 37.58 | 29.93 | 24.25 | 20.31 | 15.69 |
| Sundry debtors | 59.17 | 53.82 | 41.39 | 39.04 | 42.04 | 22.98 | 11.21 |
| Cash & bank balances | 0.11 | 0.39 | 0.31 | 2.37 | 2.16 | 1.38 | 0.66 |
| Loans & advances | 22.19 | 17.99 | 24.39 | 15.59 | 5.62 | 5.12 | 2.49 |
| Total current assets | 127 | 111 | 104 | 86.93 | 74.07 | 49.79 | 30.05 |
| Total current liabilities | 24.24 | 23.40 | 21.79 | 21.33 | 19.22 | 20.39 | 12.47 |
| Net working capital | 103 | 88.08 | 81.88 | 65.60 | 54.85 | 29.40 | 17.58 |
| Total assets | 196 | 166 | 113 | 96.01 | 63.01 | 39.93 | 21.01 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.38 | 0.31 | 1.27 | 2.16 | 1.38 | 0.66 | 0.14 |
| Net cash from operating activities | 18.77 | 26.09 | 1.36 | (7.54) | (1.72) | 1.88 | 4.18 |
| Net cash from investing activities | (18.27) | (48.90) | (1.78) | (25.10) | 2.37 | (7.84) | (3.66) |
| Net cash from financing activities | (0.78) | 22.88 | (1.07) | 31.74 | 0.13 | 6.69 | 0.00 |
| Net change in cash | (0.28) | 0.07 | (1.48) | (0.90) | 0.78 | 0.73 | 0.52 |
| Closing cash | 0.11 | 0.39 | 0.31 | 2.37 | 2.16 | 1.38 | 0.66 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +5.1% | +18.6% | +17.4% | -28.9% | +19.9% | +67.8% | - |
| EBITDA growth | -9.6% | +27.2% | +61.9% | -31.9% | -2.1% | +77.0% | - |
| PBT growth | -34.5% | +17.9% | +40.4% | -39.8% | -3.0% | +70.9% | +99.1% |
| Net income growth | -36.8% | +15.8% | +41.1% | -34.2% | -11.2% | +72.6% | - |
| Revenue CAGR (3Y) | +13.5% | -0.3% | +0.0% | +12.7% | +41.3% | +1051.1% | - |
| EBITDA CAGR (3Y) | +21.9% | +11.9% | +2.6% | +5.7% | +52.9% | +1093.3% | - |
| Profitability & leverage | |||||||
| Net income margin | +4.4% | +7.2% | +7.4% | +6.1% | +7.3% | +8.9% | +8.7% |
| Return on capital employed | +9.6% | +14.6% | +14.7% | +13.8% | +32.8% | +53.6% | +64.8% |
| Return on net worth | +7.0% | +12.5% | +12.1% | +12.6% | +41.6% | +73.5% | +101.2% |
| Debt / equity | 0.87 | 0.48 | 0.19 | 0.57 | 1.00 | 1.05 | 1.29 |
| Long-term debt / equity | 0.26 | 0.17 | 0.03 | 0.03 | 0.04 | 0.00 | 0.00 |
| Interest cover | 46.44 | 29.92 | 21.01 | 22.32 | 15.76 | 8.68 | 6.06 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 4.35 | 4.67 | 4.18 | 5.44 | 13.80 | 16.35 | 38.49 |
| Inventory turnover | 3.58 | 3.77 | 3.62 | 3.84 | 6.57 | 6.78 | 5.90 |
| Debtors turnover | 2.70 | 3.04 | 3.04 | 2.57 | 4.50 | 7.14 | 7.57 |
| EPS (₹) | 3.46 | 5.84 | 5.04 | 3.57 | 28.40 | 29.02 | 21.00 |
| Dividend per share (₹) | 0.50 | 0.50 | 0.50 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 53.89 | 49.32 | 43.99 | 39.44 | 82.48 | 54.02 | 31.25 |
To see the full year-wise statements and ratios of QMS Medical Allied Services Limited, buy the company report.
Board of directors of QMS Medical Allied Services Limited
QMS Medical Allied Services has 6 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prajwal Jayasheela Poojari | Director | 15 Jun 2022 | 4 Years 5 Months | Current |
| Niken Ravin Shah Also directs: Expandi Systems Asia LLP, X-35 Financial Technologies India LLP, Uravi Defence and Technology Limited and 2 more | Director | 11 Mar 2022 | 4 Years 8 Months | Current |
| Mahesh Pahalraj Makhija Also directs: Mayukh Healthcare Services LLP, Abae Technologies Private Limited, Queen's Promotional Services Private Limited and 2 more | Managing Director | 14 Sep 2017 | 9 Years 2 Months | Current |
| Sarita Vijay Mahajan Also directs: Kairav Chemofarbe Industries Limited | Director | 19 Nov 2024 | 1 Years 11 Months | Current |
| Deena Nath Pathak Also directs: CST Advanced Systems Private Limited, Datachurners Private Limited | Director | 23 Aug 2024 | 2 Years 2 Months | Current |
| Pranav Manhar Badheka Also directs: Palindia Computer Training Private Limited | Director | 03 Sep 2026 | 0 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 23 Dec 2024 | 101043012 | Others | ₹10 Cr | Open | |
| 11 Oct 2024 | 100988892 | Citi Bank N.A. | ₹1.2 Cr | Open | |
| 31 May 2018 | 100228986 | Citi Bank N.A. | ₹75 Cr | Open | |
| 22 Dec 2025 | 101214246 | Others | ₹10 Cr | Satisfied | |
| 09 Nov 2024 | 101011537 | Others | ₹20 Cr | Satisfied |
To see the full charge records of QMS Medical Allied Services Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
QMS Medical Allied Services Limited has 4 deals on record (2 secondary share transfers, 1 funding round, 1 ipo), with disclosed funding of ₹3.75 Cr; the latest was in October 2022.
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2022 | Secondary share transfer | Undisclosed | Buyer: Others - Qms Medical Allied Services Limited, Elara Capital Seller: Rikhav Securities Limited , IPO - Qms Medical Allied Services Limited |
| Oct 2022 | IPO | ₹56.87 Cr | Investors: IPO - Qms Medical Allied Services Limited, Rikhav Securities Limited , Sky Wanderers LLP Seller: an individual |
| Oct 2020 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: 2 individuals |
| Nov 2019 | Funding round | ₹3.75 Cr | Investors: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving QMS Medical Allied Services Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for QMS Medical Allied Services Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
QMS Medical Allied Services has 4 GST registrations: 3 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACQ4954G1ZB | Maharashtra | Active | 06 Dec 2017 |
| 29AAACQ4954G1Z7 | Karnataka | Active | 15 Apr 2024 |
| 09AAACQ4954G1Z9 | Uttar Pradesh | Active | 18 May 2024 |
To see the full GST registrations and return filing status of QMS Medical Allied Services Limited, buy the company report.
Recent activity
QMS Medical Allied Services Limited has 16 board changes on record since 2017: 6 appointments and 10 cessations. The latest: Pranav Manhar Badheka was appointed as Director on 03 Sep 2026.
25 earlier events are in the company report.
News
Frequently asked questions
QMS Medical Allied Services is an active public limited company based in Mumbai, Maharashtra, India. The company works in wholesale, within the trading industry. It was incorporated on 14 September 2017 (9+ years old) and is registered under CIN L33309MH2017PLC299748. Listed on NSE: QMSMEDI.
QMS Medical Allied Services reported revenue of ₹172.88 Cr for FY 2025-26 (up 10.8% YoY) based on consolidated financials.
QMS Medical Allied Services has 6 current directors:
- Mahesh Pahalraj Makhija - Managing Director
- Prajwal Jayasheela Poojari - Director
- Niken Ravin Shah - Director
- Sarita Vijay Mahajan - Director
- Deena Nath Pathak - Director
- Pranav Manhar Badheka - Director
The latest financial statements of QMS Medical Allied Services on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of QMS Medical Allied Services is 27AAACQ4954G1ZB, registered in Maharashtra. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 29AAACQ4954G1Z7 (Karnataka), 09AAACQ4954G1Z9 (Uttar Pradesh).
The CIN (Corporate Identification Number) of QMS Medical Allied Services is L33309MH2017PLC299748. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. QMS Medical Allied Services is a listed company as per MCA records. Its shares are listed on NSE (symbol: QMSMEDI).
QMS Medical Allied Services was incorporated on 14 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
QMS Medical Allied Services has 4 deals on record (2 secondary share transfers, 1 funding round, 1 ipo), with disclosed funding of ₹3.75 Cr; the latest was in October 2022.
Pranav Manhar Badheka was appointed as Director on 03 Sep 2026. Sarita Vijay Mahajan ceased to be Additional Director on 29 Jan 2025. Sarita Vijay Mahajan was appointed as Director on 19 Nov 2024. QMS Medical Allied Services has 16 board changes on record in total.

